Association of Pembrolizumab Infusion Time and Efficacy in Patients With Non-metastatic Triple-negative Breast Cancer (TNBC) Treated With Neoadjuvant Chemotherapy and Immunotherapy

NCT06418139 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

450

Enrollment

OTHER

Sponsor class

Conditions

Non-Metastatic Breast Carcinoma

Interventions

OTHER: No intervention

Sponsor

Assistance Publique - Hôpitaux de Paris